Haemonetics Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	TTM	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021	Mar 28, 2020	2018 - 1994
Net Income	117.56	117.56	115.4	43.38	79.47	76.53	Upgrade
Depreciation & Amortization	97.22	97.22	93.31	97.75	84.29	110.29	Upgrade
Share-Based Compensation	28.33	28.33	25.58	24.36	25.52	20.45	Upgrade
Other Operating Activities	-61.35	-61.35	38.77	6.78	-80.47	-49.05	Upgrade
Operating Cash Flow	181.75	181.75	273.06	172.26	108.81	158.22	Upgrade
Operating Cash Flow Growth	-33.44%	-33.44%	58.51%	58.32%	-31.23%	-0.67%	Upgrade
Capital Expenditures	-64.49	-64.49	-108.58	-94.49	-35.23	-31.98	Upgrade
Acquisitions	-242.35	-242.35	-2	8.14	-390.22	-25.19	Upgrade
Change in Investments	-15.55	-15.55	-33.21	0	0	0	Upgrade
Investing Cash Flow	-322.39	-322.39	-143.79	-86.35	-425.44	-57.18	Upgrade
Share Issuance / Repurchase	1.33	1.33	-67.98	6.55	10.23	-162.98	Upgrade
Debt Issued / Paid	37.75	37.75	-10.74	-17.5	357.27	31.88	Upgrade
Other Financing Activities	-0.92	-0.92	-21.64	-4.8	-0.05	-0.1	Upgrade
Financing Cash Flow	38.16	38.16	-100.36	-15.75	367.45	-131.21	Upgrade
Exchange Rate Effect	-3.19	-3.19	-3.94	-2.98	4.18	-1.87	Upgrade
Net Cash Flow	-105.67	-105.67	24.97	67.19	54.99	-32.04	Upgrade
Free Cash Flow	117.27	117.27	164.48	77.78	73.58	126.23	Upgrade
Free Cash Flow Growth	-28.70%	-28.70%	111.47%	5.70%	-41.71%	192.66%	Upgrade
Free Cash Flow Margin	8.96%	8.96%	14.07%	7.83%	8.45%	12.77%	Upgrade
Free Cash Flow Per Share	2.31	2.31	3.24	1.52	1.45	2.49	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).